In the News: US Biotech Restrictions Against China; China Regulates Non-Compete Clauses; and Hong Kong Stablecoins

U.S. pharma raises alarm over Trump’s proposed measures against Chinese drugs; China clarifies the type of employees to be bound by non-compete clauses; and Some stablecoin issuers complain that Hong Kong’s regime is too stringent.

generic drugs




US Proposes Crackdown of Chinese-Invented Treatments


The U.S. is considering tough restrictions on medicines and treatments invented in China, a move strongly opposed by U.S. pharmaceutical companies.

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]